Ensoma acquiring Twelve Bio
Ensoma is acquiring core portfolio company Twelve Bio in an all-share transaction in connection with an $85 million financing of Ensoma.
Source: labiotech.eu
Page 21 - Arix Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Arix Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Arix Bioscience Today - Breaking & Trending Today
Arix Bioscience PLC: Portfolio company Twelve Bio to be acquired alongside USD85 million financing of Ensoma
DJ Portfolio company Twelve Bio to be acquired alongside USD85 million financing of Ensoma Arix Bioscience PLC (ARIX) Portfolio company Twelve Bio to be acquired alongside USD85 million financing
Source: finanznachrichten.de
Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
Investegate announcements from Arix Bioscience PLC, Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
Source: investegate.co.uk
Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Investegate announcements from Arix Bioscience PLC, Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Source: investegate.co.uk
Disc Medicine Announces Completion of Merger with Gemini
The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market under the ticker symbol “IRON”Approximately $175 million of...
Source: globenewswire.com